StockData
Immunic, Inc. logo

Immunic, Inc. (IMUX) stock

IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$7.33+0.10 (+1.38%)

Close on Nov 17, 2026Market cap $100.01MP/E –Yield 0.00%

Immunic price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Immunic's price to book ratio was 0.9× on Nov 11, 2026, against 2.4× a year earlier. Over the last 5 years it ranged from 0.4× to 6.7×, with a median of 1.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×−4.1
2025Dec 31, 20255.0×+2.8
2024Dec 31, 20242.2×+0.8
2023Dec 29, 20231.4×+1.0
2022Dec 30, 20220.4×−1.3
2021Dec 31, 20211.7×−0.2
2020Dec 31, 20201.9×+0.3
2019Dec 31, 20191.6×−1.6
2018Jan 31, 20183.2×+0.0
2017Dec 29, 20173.2×+1.6
2016Dec 30, 20161.6×−2.2
2015Dec 31, 20153.8×−1.8
2014Dec 31, 20145.6×–

More Immunic figures

See a number that looks wrong?